Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis

References (66)

1. Immonen J, Jääskeläinen E, Korpela H, et al. Age at onset and the outcomes of schizophrenia: a systematic review and meta-analysis. Early Interv Psychiatry. 2017;11(6):453–460. PubMed CrossRef
2. Jin H, Mosweu I. The societal cost of schizophrenia: a systematic review. Pharmacoeconomics. 2017;35(1):25–42. PubMed CrossRef
3. Clemmensen L, Vernal DL, Steinhausen HC. A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry. 2012;12(1):150. PubMed CrossRef
4. McClellan J, Stock S; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013;52(9):976–990. PubMed CrossRef
5. Hegarty JD, Baldessarini RJ, Tohen M, et al. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994;151(10):1409–1416. PubMed CrossRef
6. Rajji TK, Ismail Z, Mulsant BH. Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry. 2009;195(4):286–293. PubMed CrossRef
7. Biswas P, Malhotra S, Malhotra A, et al. Comparative study of neuropsychological correlates in schizophrenia with onset in childhood, adolescence and adulthood. Eur Child Adolesc Psychiatry. 2006;15(6):360–366. PubMed CrossRef
8. Eggers C, Bunk D. The long-term course of childhood-onset schizophrenia: a 42-year followup. Schizophr Bull. 1997;23(1):105–117. PubMed CrossRef
9. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44(7):660–669. PubMed CrossRef
10. Murray RM, Lewis SW, Lecturer L. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed). 1987;295(6600):681–682. PubMed CrossRef
11. Garcia-Rizo C, Bitanihirwe BKY. Implications of early life stress on fetal metabolic programming of schizophrenia: a focus on epiphenomena underlying morbidity and early mortality. Prog Neuropsychopharmacol Biol Psychiatry. 2020;101:109910. PubMed CrossRef
12. Davies C, Segre G, Estradé A, et al. Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis. Lancet Psychiatry. 2020;7(5):399–410. PubMed CrossRef
13. Khandaker GM, Barnett JH, White IR, et al. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res. 2011;132(2-3):220–227. PubMed CrossRef
14. Parellada M, Gomez-Vallejo S, Burdeus M, et al. Developmental differences between schizophrenia and bipolar disorder. Schizophr Bull. 2017;43(6):1176–1189. PubMed CrossRef
15. Kessler RC, Amminger GP, Aguilar-Gaxiola S, et al. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20(4):359–364. PubMed CrossRef
16. Luck SJ, Leonard CJ, Hahn B, et al. Is attentional filtering impaired in schizophrenia? Schizophr Bull. 2019;45(5):1001–1011. PubMed CrossRef
17. Levy E, Traicu A, Iyer S, et al. Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap. Can J Psychiatry. 2015;60(suppl 2):S48–S52. PubMed
18. Bernardo M, Bioque M, Parellada M, et al; PEPs Group. Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev Psiquiatr Salud Ment. 2013;6(1):4–16. PubMed CrossRef
19. Bernardo M, Cabrera B, Arango C, et al. One decade of the first episodes project (PEPs): advancing towards a precision psychiatry. Rev Psiquiatr Salud Ment (Engl Ed). 2019;12(3):135–140. PubMed CrossRef
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition. Washington, DC: American Psychiatric Association; 1994.
21. Hollingshead A, Redlich F. Social Class and Mental Illness. New York NY,: Wiley; 1958.
22. Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res. 1987;21(4):413–421. PubMed CrossRef
23. Verdoux H, Geddes JR, Takei N, et al. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry. 1997;154(9):1220–1227. PubMed CrossRef
24. Wechsler D. Wechsler Intelligence Scale for Children-IV (WISC-IV). Madrid, Spain: TEA Ediciones; 2003.
25. Wechsler D. Wechsler Intelligence Scale for Adults. 2nd edition. Madrid, Spain: TEA Ediciones; 2001.
26. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470–484. PubMed CrossRef
27. Perkins DO, Leserman J, Jarskog LF, et al. Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr Res. 2000;44(1):1–10. PubMed CrossRef

28. Mezquida G, Cabrera B, Martínez-Arán A, et al. Detection of early psychotic symptoms: validation of the Spanish version of the “Symptom Onset in Schizophrenia (SOS) inventory.” Psychiatry Res. 2018;261:68–72. PubMed CrossRef

29. First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Medical Association; 1997.
30. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988. PubMed CrossRef
31. Ulloa RE, Ortiz S, Higuera F, et al. Interrater reliability of the Spanish version of Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime version (K-SADS-PL) [in Spanish]. Actas Esp Psiquiatr. 2006;34(1):36–40. PubMed
32. Sato T, Bottlender R, Schröter A, et al. Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments. Schizophr Res. 2004;67(2–3):175–183. PubMed CrossRef
33. Luoma S, Hakko H, Ollinen T, et al. Association between age at onset and clinical features of schizophrenia: the Northern Finland 1966 birth cohort study. Eur Psychiatry. 2008;23(5):331–335. PubMed CrossRef
34. White T, Ho BC, Ward J, et al. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects. Biol Psychiatry. 2006;60(5):463–471. PubMed CrossRef
35. Ballageer T, Malla A, Manchanda R, et al. Is adolescent-onset first-episode psychosis different from adult onset? J Am Acad Child Adolesc Psychiatry. 2005;44(8):782–789. PubMed CrossRef
36. Schimmelmann BG, Conus P, Cotton S, et al. Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res. 2007;95(1–3):1–8. PubMed CrossRef
37. Joa I, Johannessen JO, Langeveld J, et al. Baseline profiles of adolescent vs adult-onset first-episode psychosis in an early detection program. Acta Psychiatr Scand. 2009;119(6):494–500. PubMed CrossRef
38. Mittal VA, Ellman LM, Cannon TD. Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull. 2008;34(6):1083–1094. PubMed CrossRef
39. Scott J, McNeill Y, Cavanagh J, et al. Exposure to obstetric complications and subsequent development of bipolar disorder: systematic review. Br J Psychiatry. 2006;189(1):3–11. PubMed CrossRef
40. Guth C, Jones P, Murray R. Familial psychiatric illness and obstetric complications in early-onset affective disorder: a case-control study. Br J Psychiatry. 1993;163(4):492–498. PubMed CrossRef
41. Taylor MA, Abrams R. Early- and late-onset bipolar illness. Arch Gen Psychiatry. 1981;38(1):58–61. PubMed CrossRef
42. Rubio-Abadal E, Ochoa S, Barajas A, et al; GENIPE Group. Birth weight and obstetric complications determine age at onset in first episode of psychosis. J Psychiatr Res. 2015;65:108–114. Published online Mar 27, 2015. PubMed CrossRef
43. Grupo de trabajo de la Guía de práctica clínica de atención en el embarazo y puerperio. Guía de práctica clínica de atención en el embarazo y puerperio. Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluación de Tecnologías Sanitarias de Andalucía; 2014. https://portal.guiasalud.es/wp-content/uploads/2018/12/GPC_533_Embarazo_AETSA_compl.pdf
44. Leader J, Bajwa A, Lanes A, et al. The effect of very advanced maternal age on maternal and neonatal outcomes: a systematic review. J Obstet Gynaecol Can. 2018;40(9):1208–1218. PubMed CrossRef
45. Usta IM, Nassar AH. Advanced maternal age, part I: obstetric complications. Am J Perinatol. 2008;25(8):521–534. PubMed CrossRef
46. Maibing CF, Pedersen CB, Benros ME, et al. Risk of schizophrenia increases after all child and adolescent psychiatric disorders: a nationwide study. Schizophr Bull. 2015;41(4):963–970. PubMed CrossRef
47. Engqvist U, Rydelius PA. The occurrence and nature of early signs of schizophrenia and psychotic mood disorders among former child and adolescent psychiatric patients followed into adulthood. Child Adolesc Psychiatry Ment Health. 2008;2(1):30. PubMed CrossRef
48. Dalsgaard S, Mortensen PB, Frydenberg M, et al. Association between attention-deficit hyperactivity disorder in childhood and schizophrenia later in adulthood. Eur Psychiatry. 2014;29(4):259–263. PubMed CrossRef
49. Shyu YC, Yuan SS, Lee SY, et al. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: a nationwide population-based study in Taiwan. Schizophr Res. 2015;168(1–2):161–167. PubMed CrossRef
50. Welham J, Isohanni M, Jones P, et al. The antecedents of schizophrenia: a review of birth cohort studies. Schizophr Bull. 2009;35(3):603–623. PubMed CrossRef
51. Kendler KS, Ohlsson H, Sundquist J, et al. IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. Am J Psychiatry. 2015;172(3):259–265. PubMed CrossRef
52. Morsing E, Asard M, Ley D, et al. Cognitive function after intrauterine growth restriction and very preterm birth. Pediatrics. 2011;127(4):e874–e882. PubMed CrossRef
53. Christian P, Murray-Kolb LE, Tielsch JM, et al. Associations between preterm birth, small-for-gestational age, and neonatal morbidity and cognitive function among school-age children in Nepal. BMC Pediatr. 2014;14(1):58. PubMed CrossRef
54. Wortinger LA, Engen K, Barth C, et al. Obstetric complications and intelligence in patients on the schizophrenia-bipolar spectrum and healthy participants. Psychol Med. 2020;50(11):1914–1922. PubMed CrossRef
55. Margari F, Petruzzelli MG, Lecce PA, et al. Familial liability, obstetric complications and childhood development abnormalities in early onset schizophrenia: a case control study. BMC Psychiatry. 2011;11(1):60. PubMed CrossRef
56. Asarnow RF, Nuechterlein KH, Fogelson D, et al. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Arch Gen Psychiatry. 2001;58(6):581–588. PubMed CrossRef
57. Nicolson R, Brookner FB, Lenane M, et al. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am J Psychiatry. 2003;160(3):490–495. PubMed CrossRef
58. Hilker R, Helenius D, Fagerlund B, et al. Is an early age of illness onset in schizophrenia associated with increase genetic susceptibility? Analysis of data from the nationwide Danish twin register. EBioMedicine. 2017;18:320–326. PubMed CrossRef
59. Murray RM, Bhavsar V, Tripoli G, et al. 30 years on: how the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model of psychosis. Schizophr Bull. 2017;43(6):1190–1196. PubMed CrossRef
60. Howes OD, Murray RM. Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet. 2014;383(9929):1677–1687. Published online Dec 6, 2013. PubMed CrossRef
61. van Os J, Rutten BP, Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions [published online ahead of print October 5, 2020]. Schizophr Bull. 2008;34(6):1066–1082. PubMed CrossRef
62. Gurholt TP, Lonning V, Nerland S, et al; ENIGMA-EOP Working Group. Intracranial and subcortical volumes in adolescents with early-onset psychosis: a multisite mega-analysis from the ENIGMA consortium. Hum Brain Mapp. 2020;hbm.25212. PubMed CrossRef
63. Jalbrzikowski M, Hayes RA, Wood SJ, et al. Thinner cortex is associated with psychosis onset in individuals at clinical high risk for developing psychosis: an ENIGMA Working Group mega-analysis. medrxiv. Preprint posted online January 20, 2021.
64. Laurens KR, Cullen AE. Toward earlier identification and preventative intervention in schizophrenia: evidence from the London Child Health and Development Study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(4):475–491. PubMed CrossRef
65. Moran LV, Masters GA, Pingali S, et al. Prescription stimulant use is associated with earlier onset of psychosis. J Psychiatr Res. 2015;71:41–47. PubMed CrossRef
66. Herrero P, Contador I, Stern Y, et al. Influence of cognitive reserve in schizophrenia: a systematic review. Neurosci Biobehav Rev. 2020;108:149–159. PubMed CrossRef